Hansoh Pharmaceutical Group Company Limited Share Price OTC Markets
Equities
HNSPF
KYG549581067
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | +19.75% | -.--% | +2.73% |
04-30 | Hansoh Pharmaceutical’s 2023 Profit Up 27% | MT |
04-29 | Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024 | CI |
Sales 2024 * | 11.82B 1.63B 128B | Sales 2025 * | 12.49B 1.72B 135B | Capitalization | 91.34B 12.61B 988B |
---|---|---|---|---|---|
Net income 2024 * | 3.74B 517M 40.49B | Net income 2025 * | 3.81B 526M 41.22B | EV / Sales 2024 * | 5.93 x |
Net cash position 2024 * | 21.23B 2.93B 230B | Net cash position 2025 * | 23.86B 3.29B 258B | EV / Sales 2025 * | 5.4 x |
P/E ratio 2024 * |
24
x | P/E ratio 2025 * |
23.8
x | Employees | 9,123 |
Yield 2024 * |
1% | Yield 2025 * |
1.03% | Free-Float | 18.24% |
1 day | +19.75% | ||
3 months | +19.75% | ||
6 months | +2.73% | ||
Current year | +2.73% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 01/12/15 |
Sheng Li Zhong
SEC | Corporate Secretary | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Qiang Lin
BRD | Director/Board Member | 81 | 30/05/19 |
Sheung Wai Chan
BRD | Director/Board Member | 70 | 13/06/19 |
Dong Tao Yang
BRD | Director/Board Member | 67 | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.93% | 727B | |
-7.93% | 354B | |
+15.47% | 328B | |
-0.43% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.95% | 164B | |
-1.95% | 164B |
- Stock Market
- Equities
- 3692 Stock
- HNSPF Stock